Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning

Current Medical Research and Opinion

Volumn 28, Issue 1, 2012, Pages 3-13

  Nadeau, Daniel A ^a   Campos, Carlos ^b   Niemeyer, Marcus ^c   Bailey, Timothy ^d  

^a Diabetes and Endocrinology Associates of York Hospital   (United States)

^b Institute for Public Health and Education Research   (United States)

^c NOVO NORDISK A S   (Denmark)

^d AMCR Institute Inc   (United States)

Author keywords

Diabetes; Healthcare professionals; Learning; Preference; Prefilled insulin pen; Teaching; Usability

Indexed keywords

INSULIN;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HEALTH CARE PERSONNEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; INTERNATIONAL STANDARD UNIT; LEARNING; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; PATIENT PREFERENCE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TEACHING; TREATMENT OUTCOME;

DIABETES MELLITUS; EQUIPMENT AND SUPPLIES; HEALTH PERSONNEL; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; LEARNING; PATIENT EDUCATION AS TOPIC; PATIENTS; PROFESSIONAL-PATIENT RELATIONS; SYRINGES; TEACHING;

EID: 84855968788     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.644427     Document Type: Article

References (24)

1. Cramer JA, Pugh MJ. The influence of insulin use on glycemic control: how well do adults follow prescriptions for insulin? Diabetes Care 2005;28:78-83 (Pubitemid 40095786)
2. Asakura T, Seino H, Nakano R, et al. A comparison of the handling and accuracy of syringe and vial versus prefilled insulin pen (FlexPen). Diabetes Technol Ther 2009;11:657-61
3. Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495-7 (Pubitemid 39281409)
4. Coscelli C, Lostia S, Lunetta M, et al. Safety, efficacy, acceptability of a prefilled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract 1995;28:173-7
5. Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69-74 (Pubitemid 38112268)
6. Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999;22:137-40 (Pubitemid 29028310)
7. Arslanoglu I, Saka N, Bundak R, et al. A comparison of the use of premixed insulins in pen-injectors with conventional patient-mixed insulin treatment in children and adolescents with IDDM. Is there a decreased risk of night hypoglycemia? J Pediatr Endocrinol Metab 2000;13:313-18 (Pubitemid 30163757)
8. Bohannon NJ, Ohannesian JP, Burdan AL, et al. Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery. Clin Ther 2000;22:1049-67
9. Houtzagers CM, Berntzen PA, van der Stap H, et al. Efficacy and acceptance of two intensified conventional insulin therapy regimens: a long-term cross-over comparison. Diabet Med 1989;6:416-21 (Pubitemid 19161365)
10. Kadiri A, Chraibi A, Marouan F, et al. Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract 1998;41:15-23 (Pubitemid 28394280)
11. Korytkowski M, Bell D, Jacobsen C, et al. A multicenter, randomized, openlabel, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-48 (Pubitemid 37510593)
12. Stockl K, Ory C, Vanderplas A, et al. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin 2007;23:133-46 (Pubitemid 46191679)
13. Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712-25; discussion 0-1 (Pubitemid 44841979)
14. Hornquist JO, Wikby A, Andersson PO, et al. Insulin-pen treatment, quality of life and metabolic control: retrospective intra-group evaluations. Diabetes Res Clin Pract 1990;10:221-30
15. Piscopo MA, Chiesa G, Bonfanti R, et al. Quality of life and new devices in the management of type 1 diabetes in children and adolescents. Acta Biomed 2003;74(Suppl 1):21-5 (Pubitemid 36850818)
16. Peyrot M, Rubin RR. Factors associated with persistence and resumption of insulin pen use for patients with type 2 diabetes. Diabetes Technol Ther 2011;13:43-8
17. Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430-2
18. Hemmingsen H, Niemeyer M, Hansen MR, et al. A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens. Diabetes Technol Ther 2011;13:1207-11
19. Wielandt JO, Niemeyer M, Hansen MR, et al. An assessment of dose accuracy and injection force of a novel prefilled insulin pen: comparison with a widely used prefilled insulin pen. Expert Opin Drug Deliv 2011;8:1271-6
20. Bailey T, Thurman J, Niemeyer M, et al. Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals. Curr Med Res Opin 2011;27:2043-52
21. Oyer D, Narendran P, Qvist M, et al. Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses Expert Opin Drug Deliv 2011;8:1259-69
22. Clark PE, Valentine V, Bodie JN, et al. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens. Curr Med Res Opin 2010;26:1745-53
23. Fischer JS, Edelman SV, Schwartz SL. United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pens. J Diabetes Sci Technol 2008;2:1157-60
24. Brod M, Kongso JH, Lessard S, et al. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009;18:23-32